Asian Spectator


The Times

.

The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it – a doctor explains what researchers know about Biogen's Aduhelm

  • Written by Andrew Williams, Assistant Professor of Emergency Medicine, Albert Einstein College of Medicine
The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it – a doctor explains what researchers know about Biogen's AduhelmAn illustration of amyloid plaques within the human brain, characteristic features of Alzheimer's. By 2060, approximately 14 million Americans are expected to have the disease.Kateryna Kon/Science Photo Library via Getty Images

Medicare finalized its decision to restrict its coverage of Aduhelm, Biogen’s new Alzheimer’s disease drug, on...

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink StreamEastzlibraryzlibraryzlibrarymeybetMeritbetcasibom günceljustin tvjojobetjojobetjojobetPorno siteleri HDPadişahbetGalabetStreamEast1xbetfixbet resmi girişjojobetcasino sitelericasibomcasibomPadişahbetGalabetVipparkmarsbahistaraftarium24vippark girismarsbahisjojobet